PUBLISHER: Polaris Market Research | PRODUCT CODE: 1238770

PUBLISHER: Polaris Market Research | PRODUCT CODE: 1238770

Dravet Syndrome Market Share, Size, Trends, Industry Analysis Report, By Type of Seizures ; By Diagnosis; By Severity; By Treatment; By End-Use; By Distribution Channel; By Region; Segment Forecast, 2023 - 2032

PUBLISHED: February 1, 2023

PAGES: 126 Pages

DELIVERY TIME: 1-2 business days

SELECT AN OPTION

The global dravet syndrome market size is expected to reach USD 557.17 million by 2032, according to a new study by Polaris Market Research. The report "Dravet Syndrome Market Share, Size, Trends, Industry Analysis Report, By Type of seizures (Myoclonic seizures, Atonic seizures, Partial seizures, Tonic-clonic seizures, photosensitive seizures Others); By Diagnosis; By Severity; By Treatment; By End-Use; By Distribution Channel; By Region; Segment Forecast, 2023 - 2032" gives a detailed insight into current market dynamics and provides analysis on future market growth.

The market's revenue growth will most likely be driven by enhanced genetic testing, which has increased the probability of Dravet syndrome diagnosis. An increase in improved regulatory environment for the healthcare sector and government funding for R&D has contributed to growth in the revenue of market. Improved healthcare infrastructure and greater healthcare budgets are expected to promote market revenue growth during the projected period. Increasing R&D initiatives for the discovery of innovative medications for syndrome are projected to drive growth in the future.

The U.S. FDA authorized the approval of the Diacomit in August 2020, for treating seizures linked with Dravet syndrome. Drug market share is expected to expand significantly after 2020 as a result of improved efficiency, safety, & longer seizure relief. Dravet syndrome is an exceedingly unusual neurological disorder that is typically lifelong. According to the Dravet Foundation, 1 in every 15,700 newborns born in the United States has Dravet syndrome.

Encoded's precision gene therapy seeks to treat gait issues, ataxia (poor coordination), and developmental delays. It is intended to treat mutations in the SCN1A gene, which are the cause of the majority of Dravet cases, by increasing endogenous SCN1A expression in a particular cell type in the brain. The therapy increased SCN1A expression in a subset of inhibitory interneurons. Encoded intends to begin clinical trials for the therapy in early 2021. As numerous rich nations face a failure of these specifics, the increased demand for COVID-19 operation curatives has created enormous eventualities for manufacturers. Because of the need for vaccinations and treatment specifics for COVID-19, biopharma assiduity is likely to increase significantly in future. This, in turn, is projected to have a major influence on the dravet syndrome market as an effect of COVID-19.

Dravet Syndrome Market Report Highlights:

Myoclonic Seizures held the largest revenue share as it affects both sides of the brain simultaneously. It is widely used for children with Dravet syndrome and other epileptic conditions.
The hospital pharmacies lead the market segment because of the availability and accessibility of innovative therapies and equipment.
The global players include: Biscayne, Cyberonics, INSYS Therapeutics, Epygenix Therapeutics, GW Pharmaceuticals, Ovid Therapeutics, PTC Therapeutics, Sage Therapeutics, Takeda Pharmaceutical, ThermoFisher Life, OPKO Health, Xenon Pharmaceutical, and Zogenix.

Polaris Market Research has segmented the Dravet syndrome market report based on form type of seizures, diagnosis, severity, treatment, end-use, distribution channel, and region:

Dravet Syndrome, Type of seizures Outlook (Revenue - USD Million, 2019 - 2032)

Myoclonic Seizures
Atonic Seizures
Partial Seizures
Tonic-Clonic Seizures
Photosensitive seizures
Others

Dravet Syndrome, Diagnosis Outlook (Revenue - USD Million, 2019 - 2032)

MRI
EEG
SCN1A testing

Dravet Syndrome, Severity Outlook (Revenue - USD Million, 2019 - 2032)

Mild
Moderate
Severe

Dravet Syndrome, Treatment Outlook (Revenue - USD Million, 2019 - 2032)

Seizure Medication
Clobazam
Stiripentol
Sodium Valproate
Others
Ketogenic Diet
Vagus Nerve Stimulation

Dravet Syndrome, End-Use Outlook (Revenue - USD Million, 2019 - 2032)

Pharmaceutical companies
Hospitals
Diagnostic Laboratories
Academic and Research Institutions
Others

Dravet Syndrome, Distribution Channel Outlook (Revenue - USD Million, 2019 - 2032)

Direct tender
Hospital pharmacy
Retail Pharmacy
Others

Dravet Syndrome, Regional Outlook (Revenue - USD Million, 2019 - 2032)

North America
- U.S.
- Canada

Europe
- Germany
- UK
- France
- Italy
- Spain
- Russia
- Netherlands

Asia Pacific
- China
- India
- Japan
- South Korea
- Indonesia
- Malaysia

Latin America
- Argentina
- Brazil
- Mexico

Middle East & Africa
- UAE
- Saudi Arabia
- Israel
- South Africa

Product Code: PM3033

1. Introduction

1.1. Report Description
- 1.1.1. Objectives of the Study
- 1.1.2. Market Scope
- 1.1.3. Assumptions
1.2. Stakeholders

2. Executive Summary

2.1. Market Highlights

3. Research Methodology

3.1. Overview
- 3.1.1. Data Mining
3.2. Data Sources
- 3.2.1. Primary Sources
- 3.2.2. Secondary Sources

4. Global Dravet Syndrome Market Insights

4.1. Dravet Syndrome - Industry Snapshot
4.2. Dravet Syndrome Market Dynamics
- 4.2.1. Drivers and Opportunities
  - 4.2.1.1. Increased government investment in R&D
  - 4.2.1.2. Availability of favorable reimbursement policies
- 4.2.2. Restraints and Challenges
  - 4.2.2.1. Drug-related adverse effects and the high cost of existing treatments.
4.3. Porter's Five Forces Analysis
- 4.3.1. Bargaining Power of Suppliers (Moderate)
- 4.3.2. Threats of New Entrants: (Low)
- 4.3.3. Bargaining Power of Buyers (Moderate)
- 4.3.4. Threat of Substitute (Moderate)
- 4.3.5. Rivalry among existing firms (High)
4.4. PESTLE Analysis
4.5. Dravet Syndrome Industry Trends
4.6. COVID-19 Impact Analysis

5. Global Dravet Syndrome Market, by Diagnosis

5.1. Key Findings
5.2. Introduction
- 5.2.1. Global Dravet Syndrome Market, by Diagnosis, 2019-2032 (USD Million)
5.3. MRI
- 5.3.1. Global Dravet Syndrome Market, by MRI, by Region, 2019-2032 (USD Million)
5.4. ECG
- 5.4.1. Global Dravet Syndrome Market, by ECG, by Region, 2019-2032 (USD Million)
5.5. SCN1A testing
- 5.5.1. Global Dravet Syndrome Market, by SCN1A testing, by Region, 2019-2032 (USD Million)

6. Global Dravet Syndrome Market, by Severity

6.1. Key Findings
6.2. Introduction
- 6.2.1. Global Dravet Syndrome Market, by Severity, 2019-2032 (USD Million)
6.3. Mild
- 6.3.1. Global Dravet Syndrome Market, by Mild, by Region, 2019-2032 (USD Million)
6.4. Moderate
- 6.4.1. Global Dravet Syndrome Market, by Moderate, by Region, 2019-2032 (USD Million)
6.5. Severe
- 6.5.1. Global Dravet Syndrome Market, by Severe, by Region, 2019-2032 (USD Million)

7. Global Dravet Syndrome Market, by Treatment

7.1. Key Findings
7.2. Introduction
- 7.2.1. Global Dravet Syndrome Market, by Treatment, 2019-2032 (USD Million)
7.3. Seizure
- 7.3.1. Global Dravet Syndrome Market, by Seizure, by Region, 2019-2032 (USD Million)
7.4. Medication
- 7.4.1. Global Dravet Syndrome Market, by Medication, by Region, 2019-2032 (USD Million)
7.5. Clobazam
- 7.5.1. Global Dravet Syndrome Market, by Clobazam, by Region, 2019-2032 (USD Million)
7.6. Stiripentol
- 7.6.1. Global Dravet Syndrome Market, by Stiripentol, by Region, 2019-2032 (USD Million)
7.7. Sodium Valproate
- 7.7.1. Global Other Dravet Syndrome Market, by Sodium Valproate, by Region, 2019-2032 (USD Million)
7.8. Others
- 7.8.1. Global Other Dravet Syndrome Market, by Others, by Region, 2019-2032 (USD Million)
7.9. Ketogenic diet
- 7.9.1. Global Other Dravet Syndrome Market, by Ketogenic diet, by Region, 2019-2032 (USD Million)
7.10. Vagus Nerve stimulation
- 7.10.1. Global Other Dravet Syndrome Market, by Vagus Nerve stimulation, by Region, 2019-2032 (USD Million)

8. Global Dravet Syndrome Market, by Distribution Channel

8.1. Key Findings
8.2. Introduction
- 8.2.1. Global Dravet Syndrome Market, by Distribution Channel, 2019-2032 (USD Million)
8.3. Direct Tender
- 8.3.1. Global Dravet Syndrome Market, by Direct Tender, by Region, 2019-2032 (USD Million)
8.4. Hospital pharmacy
- 8.4.1. Global Dravet Syndrome Market, by Hospital pharmacy, by Region, 2019-2032 (USD Million)
8.5. Retail Pharmacy
- 8.5.1. Global Dravet Syndrome Market, by Retail Pharmacy, by Region, 2019-2032 (USD Million)
8.6. Others
- 8.6.1. Global Dravet Syndrome Market, by Others, by Region, 2019-2032 (USD Million)

9. Global Dravet Syndrome Market, by Type of seizures

9.1. Key Findings
9.2. Introduction
- 9.2.1. Global Dravet Syndrome Market, by Type of seizures, 2019-2032 (USD Million)
9.3. Myoclonic Seizures
- 9.3.1. Global Dravet Syndrome Market, by Myoclonic Seizures, by Region, 2019-2032 (USD Million)
9.4. Atonic Seizures
- 9.4.1. Global Dravet Syndrome Market, by Atonic Seizures, by Region, 2019-2032 (USD Million)
9.5. Partial Seizures
- 9.5.1. Global Dravet Syndrome Market, by Partial Seizures, by Region, 2019-2032 (USD Million)
9.6. Tonic-Clonic Seizures
- 9.6.1. Global Dravet Syndrome Market, by Tonic-Clonic Seizures, by Region, 2019-2032 (USD Million)
9.7. Photosensitive seizures
- 9.7.1. Global Dravet Syndrome Market, by Photosensitive seizures, by Region, 2019-2032 (USD Million)
9.8. Others
- 9.8.1. Global Dravet Syndrome Market, by Others, by Region, 2019-2032 (USD Million)

10. Global Dravet Syndrome Market, by End-Use

10.1. Key Findings
10.2. Introduction
- 10.2.1. Global Dravet Syndrome Market, by End-Use, 2019-2032 (USD Million)
10.3. Pharma companies
- 10.3.1. Global Dravet Syndrome Market, by Pharma companies, by Region, 2019-2032 (USD Million)
10.4. Hospitals
- 10.4.1. Global Dravet Syndrome Market, by Hospitals, by Region, 2019-2032 (USD Million)
10.5. Diagnostic Laboratories
- 10.5.1. Global Dravet Syndrome Market, by Diagnostic Laboratories, by Region, 2019-2032 (USD Million)
10.6. Academic and Research Institutes
- 10.6.1. Global Dravet Syndrome Market, by Academic and Research Institutes, by Region, 2019-2032 (USD Million)
10.7. Others
- 10.7.1. Global Other End-Uses Dravet Syndrome Market, by Region, 2019-2032 (USD Million)

11. Global Dravet Syndrome Market, by Geography

11.1. Key findings
11.2. Introduction
- 11.2.1. Dravet Syndrome Market Assessment, By Geography, 2019-2032 (USD Million)
11.3. Dravet Syndrome Market - North America
- 11.3.1. North America: Dravet Syndrome Market, by Diagnosis, 2019-2032 (USD Million)
- 11.3.2. North America: Dravet Syndrome Market, by Distribution Channel, 2019-2032 (USD Million)
- 11.3.3. North America: Dravet Syndrome Market, by Severity, 2019-2032 (USD Million)
- 11.3.4. North America: Dravet Syndrome Market, by Type of seizures, 2019-2032 (USD Million)
- 11.3.5. North America: Dravet Syndrome Market, by Treatment, 2019-2032 (USD Million)
- 11.3.6. North America: Dravet Syndrome Market, by End-Use, 2019-2032 (USD Million)
- 11.3.7. Dravet Syndrome Market - U.S.
  - 11.3.7.1. U.S.: Dravet Syndrome Market, by Diagnosis, 2019-2032 (USD Million)
  - 11.3.7.2. U.S.: Dravet Syndrome Market, by Distribution Channel, 2019-2032 (USD Million)
  - 11.3.7.3. U.S.: Dravet Syndrome Market, by Severity, 2019-2032 (USD Million)
  - 11.3.7.4. U.S.: Dravet Syndrome Market, by Type of seizures, 2019-2032 (USD Million)
  - 11.3.7.5. U.S.: Dravet Syndrome Market, by Treatment, 2019-2032 (USD Million)
  - 11.3.7.6. U.S.: Dravet Syndrome Market, by End-Use, 2019-2032 (USD Million)
- 11.3.8. Dravet Syndrome Market - Canada
  - 11.3.8.1. Canada: Dravet Syndrome Market, by Diagnosis, 2019-2032 (USD Million)
  - 11.3.8.2. Canada.: Dravet Syndrome Market, by Distribution Channel, 2019-2032 (USD Million)
  - 11.3.8.3. Canada: Dravet Syndrome Market, by Severity, 2019-2032 (USD Million)
  - 11.3.8.4. Canada: Dravet Syndrome Market, by Type of seizures, 2019-2032 (USD Million)
  - 11.3.8.5. Canada: Dravet Syndrome Market, by Treatment, 2019-2032 (USD Million)
  - 11.3.8.6. Canada: Dravet Syndrome Market, by End-Use, 2019-2032 (USD Million)
11.4. Dravet Syndrome Market - Europe
- 11.4.1. Europe: Dravet Syndrome Market, by Diagnosis, 2019-2032 (USD Million)
- 11.4.2. Europe.: Dravet Syndrome Market, by Distribution Channel, 2019-2032 (USD Million)
- 11.4.3. Europe: Dravet Syndrome Market, by Severity, 2019-2032 (USD Million)
- 11.4.4. Europe: Dravet Syndrome Market, by Type of seizures, 2019-2032 (USD Million)
- 11.4.5. Europe: Dravet Syndrome Market, by Treatment, 2019-2032 (USD Million)
- 11.4.6. Europe: Dravet Syndrome Market, by End-Use, 2019-2032 (USD Million)
- 11.4.7. Dravet Syndrome Market - UK
  - 11.4.7.1. UK: Dravet Syndrome Market, by Diagnosis, 2019-2032 (USD Million)
  - 11.4.7.2. UK.: Dravet Syndrome Market, by Distribution Channel, 2019-2032 (USD Million)
  - 11.4.7.3. UK: Dravet Syndrome Market, by Severity, 2019-2032 (USD Million)
  - 11.4.7.4. UK: Dravet Syndrome Market, by Type of seizures, 2019-2032 (USD Million)
  - 11.4.7.5. UK: Dravet Syndrome Market, by Treatment, 2019-2032 (USD Million)
  - 11.4.7.6. UK: Dravet Syndrome Market, by End-Use, 2019-2032 (USD Million)
- 11.4.8. Dravet Syndrome Market - France
  - 11.4.8.1. France: Dravet Syndrome Market, by Diagnosis, 2019-2032 (USD Million)
  - 11.4.8.2. France.: Dravet Syndrome Market, by Distribution Channel, 2019-2032 (USD Million)
  - 11.4.8.3. France: Dravet Syndrome Market, by Severity, 2019-2032 (USD Million)
  - 11.4.8.4. France: Dravet Syndrome Market, by Type of seizures, 2019-2032 (USD Million)
  - 11.4.8.5. France: Dravet Syndrome Market, by Treatment, 2019-2032 (USD Million)
  - 11.4.8.6. France: Dravet Syndrome Market, by End-Use, 2019-2032 (USD Million)
- 11.4.9. Dravet Syndrome Market - Germany
  - 11.4.9.1. Germany: Dravet Syndrome Market, by Diagnosis, 2019-2032 (USD Million)
  - 11.4.9.2. Germany.: Dravet Syndrome Market, by Distribution Channel, 2019-2032 (USD Million)
  - 11.4.9.3. Germany: Dravet Syndrome Market, by Severity, 2019-2032 (USD Million)
  - 11.4.9.4. Germany: Dravet Syndrome Market, by Type of seizures, 2019-2032 (USD Million)
  - 11.4.9.5. Germany: Dravet Syndrome Market, by Treatment, 2019-2032 (USD Million)
  - 11.4.9.6. Germany: Dravet Syndrome Market, by End-Use, 2019-2032 (USD Million)
- 11.4.10. Dravet Syndrome Market - Italy
  - 11.4.10.1. Italy: Dravet Syndrome Market, by Diagnosis, 2019-2032 (USD Million)
  - 11.4.10.2. Italy.: Dravet Syndrome Market, by Distribution Channel, 2019-2032 (USD Million)
  - 11.4.10.3. Italy: Dravet Syndrome Market, by Severity, 2019-2032 (USD Million)
  - 11.4.10.4. Italy: Dravet Syndrome Market, by Type of seizures, 2019-2032 (USD Million)
  - 11.4.10.5. Italy: Dravet Syndrome Market, by Treatment, 2019-2032 (USD Million)
  - 11.4.10.6. Italy: Dravet Syndrome Market, by End-Use, 2019-2032 (USD Million)
- 11.4.11. Dravet Syndrome Market - Spain
  - 11.4.11.1. Spain: Dravet Syndrome Market, by Diagnosis, 2019-2032 (USD Million)
  - 11.4.11.2. Spain.: Dravet Syndrome Market, by Distribution Channel, 2019-2032 (USD Million)
  - 11.4.11.3. Spain: Dravet Syndrome Market, by Severity, 2019-2032 (USD Million)
  - 11.4.11.4. Spain: Dravet Syndrome Market, by Type of seizures, 2019-2032 (USD Million)
  - 11.4.11.5. Spain: Dravet Syndrome Market, by Treatment, 2019-2032 (USD Million)
  - 11.4.11.6. Spain: Dravet Syndrome Market, by End-Use, 2019-2032 (USD Million)
- 11.4.12. Dravet Syndrome Market - Netherlands
  - 11.4.12.1. Netherlands: Dravet Syndrome Market, by Diagnosis, 2019-2032 (USD Million)
  - 11.4.12.2. Netherlands.: Dravet Syndrome Market, by Distribution Channel, 2019-2032 (USD Million)
  - 11.4.12.3. Netherlands: Dravet Syndrome Market, by Severity, 2019-2032 (USD Million)
  - 11.4.12.4. Netherlands: Dravet Syndrome Market, by Type of seizures, 2019-2032 (USD Million)
  - 11.4.12.5. Netherlands: Dravet Syndrome Market, by Treatment, 2019-2032 (USD Million)
  - 11.4.12.6. Netherlands: Dravet Syndrome Market, by End-Use, 2019-2032 (USD Million)
- 11.4.13. Dravet Syndrome Market - Russia
  - 11.4.13.1. Russia: Dravet Syndrome Market, by Diagnosis, 2019-2032 (USD Million)
  - 11.4.13.2. Russia.: Dravet Syndrome Market, by Distribution Channel, 2019-2032 (USD Million)
  - 11.4.13.3. Russia: Dravet Syndrome Market, by Severity, 2019-2032 (USD Million)
  - 11.4.13.4. Russia: Dravet Syndrome Market, by Type of seizures, 2019-2032 (USD Million)
  - 11.4.13.5. Russia: Dravet Syndrome Market, by Treatment, 2019-2032 (USD Million)
  - 11.4.13.6. Russia: Dravet Syndrome Market, by End-Use, 2019-2032 (USD Million)
11.5. Dravet Syndrome Market - Asia Pacific
- 11.5.1. Asia Pacific: Dravet Syndrome Market, by Diagnosis, 2019-2032 (USD Million)
- 11.5.2. Asia Pacific.: Dravet Syndrome Market, by Distribution Channel, 2019-2032 (USD Million)
- 11.5.3. Asia Pacific: Dravet Syndrome Market, by Severity, 2019-2032 (USD Million)
- 11.5.4. Asia Pacific: Dravet Syndrome Market, by Type of seizures, 2019-2032 (USD Million)
- 11.5.5. Asia Pacific: Dravet Syndrome Market, by Treatment, 2019-2032 (USD Million)
- 11.5.6. Asia Pacific: Dravet Syndrome Market, by End-Use, 2019-2032 (USD Million)
- 11.5.7. Dravet Syndrome Market - China
  - 11.5.7.1. China: Dravet Syndrome Market, by Diagnosis, 2019-2032 (USD Million)
  - 11.5.7.2. China.: Dravet Syndrome Market, by Distribution Channel, 2019-2032 (USD Million)
  - 11.5.7.3. China: Dravet Syndrome Market, by Severity, 2019-2032 (USD Million)
  - 11.5.7.4. China: Dravet Syndrome Market, by Type of seizures, 2019-2032 (USD Million)
  - 11.5.7.5. China: Dravet Syndrome Market, by Treatment, 2019-2032 (USD Million)
  - 11.5.7.6. China: Dravet Syndrome Market, by End-Use, 2019-2032 (USD Million)
- 11.5.8. Dravet Syndrome Market - India
  - 11.5.8.1. India: Dravet Syndrome Market, by Diagnosis, 2019-2032 (USD Million)
  - 11.5.8.2. India.: Dravet Syndrome Market, by Distribution Channel, 2019-2032 (USD Million)
  - 11.5.8.3. India: Dravet Syndrome Market, by Severity, 2019-2032 (USD Million)
  - 11.5.8.4. India: Dravet Syndrome Market, by Type of seizures, 2019-2032 (USD Million)
  - 11.5.8.5. India: Dravet Syndrome Market, by Treatment, 2019-2032 (USD Million)
  - 11.5.8.6. India: Dravet Syndrome Market, by End-Use, 2019-2032 (USD Million)
- 11.5.9. Dravet Syndrome Market - Japan
  - 11.5.9.1. Japan: Dravet Syndrome Market, by Diagnosis, 2019-2032 (USD Million)
  - 11.5.9.2. Japan.: Dravet Syndrome Market, by Distribution Channel, 2019-2032 (USD Million)
  - 11.5.9.3. Japan: Dravet Syndrome Market, by Severity, 2019-2032 (USD Million)
  - 11.5.9.4. Japan: Dravet Syndrome Market, by Type of seizures, 2019-2032 (USD Million)
  - 11.5.9.5. Japan: Dravet Syndrome Market, by Treatment, 2019-2032 (USD Million)
  - 11.5.9.6. Japan: Dravet Syndrome Market, by End-Use, 2019-2032 (USD Million)
- 11.5.10. Dravet Syndrome Market - Malaysia
  - 11.5.10.1. Malaysia: Dravet Syndrome Market, by Diagnosis, 2019-2032 (USD Million)
  - 11.5.10.2. Malaysia.: Dravet Syndrome Market, by Distribution Channel, 2019-2032 (USD Million)
  - 11.5.10.3. Malaysia: Dravet Syndrome Market, by Severity, 2019-2032 (USD Million)
  - 11.5.10.4. Malaysia: Dravet Syndrome Market, by Type of seizures, 2019-2032 (USD Million)
  - 11.5.10.5. Malaysia: Dravet Syndrome Market, by Treatment, 2019-2032 (USD Million)
  - 11.5.10.6. Malaysia: Dravet Syndrome Market, by End-Use, 2019-2032 (USD Million)
- 11.5.11. Dravet Syndrome Market - Indonesia
  - 11.5.11.1. Indonesia: Dravet Syndrome Market, by Diagnosis, 2019-2032 (USD Million)
  - 11.5.11.2. Indonesia.: Dravet Syndrome Market, by Distribution Channel, 2019-2032 (USD Million)
  - 11.5.11.3. Indonesia: Dravet Syndrome Market, by Severity, 2019-2032 (USD Million)
  - 11.5.11.4. Indonesia: Dravet Syndrome Market, by Type of seizures, 2019-2032 (USD Million)
  - 11.5.11.5. Indonesia: Dravet Syndrome Market, by Treatment, 2019-2032 (USD Million)
  - 11.5.11.6. Indonesia: Dravet Syndrome Market, by End-Use, 2019-2032 (USD Million)
- 11.5.12. Dravet Syndrome Market - South Korea
  - 11.5.12.1. South Korea: Dravet Syndrome Market, by Diagnosis, 2019-2032 (USD Million)
  - 11.5.12.2. South Korea.: Dravet Syndrome Market, by Distribution Channel, 2019-2032 (USD Million)
  - 11.5.12.3. South Korea: Dravet Syndrome Market, by Severity, 2019-2032 (USD Million)
  - 11.5.12.4. South Korea: Dravet Syndrome Market, by Type of seizures, 2019-2032 (USD Million)
  - 11.5.12.5. South Korea: Dravet Syndrome Market, by Treatment, 2019-2032 (USD Million)
  - 11.5.12.6. South Korea: Dravet Syndrome Market, by End-Use, 2019-2032 (USD Million)
11.6. Dravet Syndrome Market - Middle East & Africa
- 11.6.1. Middle East & Africa: Dravet Syndrome Market, by Diagnosis, 2019-2032 (USD Million)
- 11.6.2. Middle East & Africa: Dravet Syndrome Market, by Distribution Channel, 2019-2032 (USD Million)
- 11.6.3. Middle East & Africa: Dravet Syndrome Market, by Severity, 2019-2032 (USD Million)
- 11.6.4. Middle East & Africa: Dravet Syndrome Market, by Type of seizures, 2019-2032 (USD Million)
- 11.6.5. Middle East & Africa: Dravet Syndrome Market, by Treatment, 2019-2032 (USD Million)
- 11.6.6. Middle East & Africa: Dravet Syndrome Market, by End-Use, 2019-2032 (USD Million)
- 11.6.7. Dravet Syndrome Market - Saudi Arabia
  - 11.6.7.1. Saudi Arabia: Dravet Syndrome Market, by Diagnosis, 2019-2032 (USD Million)
  - 11.6.7.2. Saudi Arabia.: Dravet Syndrome Market, by Distribution Channel, 2019-2032 (USD Million)
  - 11.6.7.3. Saudi Arabia: Dravet Syndrome Market, by Severity, 2019-2032 (USD Million)
  - 11.6.7.4. Saudi Arabia: Dravet Syndrome Market, by Type of seizures, 2019-2032 (USD Million)
  - 11.6.7.5. Saudi Arabia: Dravet Syndrome Market, by Treatment, 2019-2032 (USD Million)
  - 11.6.7.6. Saudi Arabia: Dravet Syndrome Market, by End-Use, 2019-2032 (USD Million)
- 11.6.8. Dravet Syndrome Market - UAE
  - 11.6.8.1. UAE: Dravet Syndrome Market, by Diagnosis, 2019-2032 (USD Million)
  - 11.6.8.2. UAE.: Dravet Syndrome Market, by Distribution Channel, 2019-2032 (USD Million)
  - 11.6.8.3. UAE: Dravet Syndrome Market, by Severity, 2019-2032 (USD Million)
  - 11.6.8.4. UAE: Dravet Syndrome Market, by Type of seizures, 2019-2032 (USD Million)
  - 11.6.8.5. UAE: Dravet Syndrome Market, by Treatment, 2019-2032 (USD Million)
  - 11.6.8.6. UAE: Dravet Syndrome Market, by End-Use, 2019-2032 (USD Million)
- 11.6.9. Dravet Syndrome Market - Israel
  - 11.6.9.1. Israel: Dravet Syndrome Market, by Diagnosis, 2019-2032 (USD Million)
  - 11.6.9.2. Israel.: Dravet Syndrome Market, by Distribution Channel, 2019-2032 (USD Million)
  - 11.6.9.3. Israel: Dravet Syndrome Market, by Severity, 2019-2032 (USD Million)
  - 11.6.9.4. Israel: Dravet Syndrome Market, by Type of seizures, 2019-2032 (USD Million)
  - 11.6.9.5. Israel: Dravet Syndrome Market, by Treatment, 2019-2032 (USD Million)
  - 11.6.9.6. Israel: Dravet Syndrome Market, by End-Use, 2019-2032 (USD Million)
- 11.6.10. Dravet Syndrome Market - South Africa
  - 11.6.10.1. South Africa: Dravet Syndrome Market, by Diagnosis, 2019-2032 (USD Million)
  - 11.6.10.2. South Africa.: Dravet Syndrome Market, by Distribution Channel, 2019-2032 (USD Million)
  - 11.6.10.3. South Africa: Dravet Syndrome Market, by Severity, 2019-2032 (USD Million)
  - 11.6.10.4. South Africa: Dravet Syndrome Market, by Type of seizures, 2019-2032 (USD Million)
  - 11.6.10.5. South Africa: Dravet Syndrome Market, by Treatment, 2019-2032 (USD Million)
  - 11.6.10.6. South Africa: Dravet Syndrome Market, by End-Use, 2019-2032 (USD Million)
11.7. Dravet Syndrome Market - Latin America
- 11.7.1. Latin America: Dravet Syndrome Market, by Diagnosis, 2019-2032 (USD Million)
- 11.7.2. Latin America.: Dravet Syndrome Market, by Distribution Channel, 2019-2032 (USD Million)
- 11.7.3. Latin America: Dravet Syndrome Market, by Severity, 2019-2032 (USD Million)
- 11.7.4. Latin America: Dravet Syndrome Market, by Type of seizures, 2019-2032 (USD Million)
- 11.7.5. Latin America: Dravet Syndrome Market, by Treatment, 2019-2032 (USD Million)
- 11.7.6. Latin America: Dravet Syndrome Market, by End-Use, 2019-2032 (USD Million)
- 11.7.7. Dravet Syndrome Market - Mexico
  - 11.7.7.1. Mexico: Dravet Syndrome Market, by Diagnosis, 2019-2032 (USD Million)
  - 11.7.7.2. Mexico.: Dravet Syndrome Market, by Distribution Channel, 2019-2032 (USD Million)
  - 11.7.7.3. Mexico: Dravet Syndrome Market, by Severity, 2019-2032 (USD Million)
  - 11.7.7.4. Mexico: Dravet Syndrome Market, by Type of seizures, 2019-2032 (USD Million)
  - 11.7.7.5. Mexico: Dravet Syndrome Market, by Treatment, 2019-2032 (USD Million)
  - 11.7.7.6. Mexico: Dravet Syndrome Market, by End-Use, 2019-2032 (USD Million)
- 11.7.8. Dravet Syndrome Market - Brazil
  - 11.7.8.1. Brazil: Dravet Syndrome Market, by Diagnosis, 2019-2032 (USD Million)
  - 11.7.8.2. Brazil.: Dravet Syndrome Market, by Distribution Channel, 2019-2032 (USD Million)
  - 11.7.8.3. Brazil: Dravet Syndrome Market, by Severity, 2019-2032 (USD Million)
  - 11.7.8.4. Brazil: Dravet Syndrome Market, by Type of seizures, 2019-2032 (USD Million)
  - 11.7.8.5. Brazil: Dravet Syndrome Market, by Treatment, 2019-2032 (USD Million)
  - 11.7.8.6. Brazil: Dravet Syndrome Market, by End-Use, 2019-2032 (USD Million)
- 11.7.9. Dravet Syndrome Market - Argentina
  - 11.7.9.1. Argentina: Dravet Syndrome Market, by Diagnosis, 2019-2032 (USD Million)
  - 11.7.9.2. Argentina.: Dravet Syndrome Market, by Distribution Channel, 2019-2032 (USD Million)
  - 11.7.9.3. Argentina: Dravet Syndrome Market, by Severity, 2019-2032 (USD Million)
  - 11.7.9.4. Argentina: Dravet Syndrome Market, by Type of seizures, 2019-2032 (USD Million)
  - 11.7.9.5. Argentina: Dravet Syndrome Market, by Treatment, 2019-2032 (USD Million)
  - 11.7.9.6. Argentina: Dravet Syndrome Market, by End-Use, 2019-2032 (USD Million)

12. Competitive Landscape

12.1. Expansion and Acquisition Analysis
- 12.1.1. Expansion
- 12.1.2. Acquisitions
12.2. Partnerships/Collaborations/Agreements/Exhibitions

13. Company Profiles

13.1. Biscayne Neurotherapeutics
- 13.1.1. Company Overview
- 13.1.2. Financial Performance
- 13.1.3. Product Benchmarking
- 13.1.4. Recent Development
13.2. Epygenix Therapeutics
- 13.2.1. Company Overview
- 13.2.2. Financial Performance
- 13.2.3. Product Benchmarking
- 13.2.4. Recent Development
13.3. OPKO Health
- 13.3.1. Company Overview
- 13.3.2. Financial Performance
- 13.3.3. Product Benchmarking
- 13.3.4. Recent Development
13.4. GW Pharmaceuticals
- 13.4.1. Company Overview
- 13.4.2. Financial Performance
- 13.4.3. Product Benchmarking
- 13.4.4. Recent Development
13.5. Ovid Therapeutics
- 13.5.1. Company Overview
- 13.5.2. Financial Performance
- 13.5.3. Product Benchmarking
- 13.5.4. Recent Development
13.6. PTC Therapeutics
- 13.6.1. Company Overview
- 13.6.2. Financial Performance
- 13.6.3. Product Benchmarking
- 13.6.4. Recent Development
13.7. Sage Therapeutics
- 13.7.1. Company Overview
- 13.7.2. Financial Performance
- 13.7.3. Product Benchmarking
- 13.7.4. Recent Development
13.8. INSYS Therapeutics
- 13.8.1. Company Overview
- 13.8.2. Financial Performance
- 13.8.3. Product Benchmarking
- 13.8.4. Recent Development
13.9. Takeda Pharmaceutical
- 13.9.1. Company Overview
- 13.9.2. Financial Performance
- 13.9.3. Product Benchmarking
- 13.9.4. Recent Development
13.10. ThermoFisher Life
- 13.10.1. Company Overview
- 13.10.2. Financial Performance
- 13.10.3. Product Benchmarking
- 13.10.4. Recent Development
13.11. Xenon Pharmaceutical
- 13.11.1. Company Overview
- 13.11.2. Financial Performance
- 13.11.3. Product Benchmarking
- 13.11.4. Recent Development
13.12. Zogenix Inc.
- 13.12.1. Company Overview
- 13.12.2. Financial Performance
- 13.12.3. Product Benchmarking
- 13.12.4. Recent Development

Product Code: PM3033

List of Tables

Table 1 Global Dravet Syndrome Market, by Diagnosis, by Region, 2019-2032 (USD Million)
Table 2 Global Dravet Syndrome Market, by Distribution Channel, by Region, 2019-2032 (USD Million)
Table 3 Global Dravet Syndrome Market, by Severity, by Region, 2019-2032 (USD Million)
Table 4 Global Dravet Syndrome Market, by Type of seizures, by Region, 2019-2032 (USD Million)
Table 5 Global Dravet Syndrome Market, by Treatment, by Region, 2019-2032 (USD Million)
Table 6 Global Dravet Syndrome Market, by End-Use, by Region, 2019-2032 (USD Million)

Have a question?

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Christine Sirois

Manager - Americas

+1-860-674-8796

SEE OUR FAQ

Dravet Syndrome Market Share, Size, Trends, Industry Analysis Report, By Type of Seizures ; By Diagnosis; By Severity; By Treatment; By End-Use; By Distribution Channel; By Region; Segment Forecast, 2023 - 2032

Description

Table of Contents

List of Tables

Dravet Syndrome Market Report Highlights:

Dravet Syndrome, Type of seizures Outlook (Revenue - USD Million, 2019 - 2032)

Dravet Syndrome, Diagnosis Outlook (Revenue - USD Million, 2019 - 2032)

Dravet Syndrome, Severity Outlook (Revenue - USD Million, 2019 - 2032)

Dravet Syndrome, Treatment Outlook (Revenue - USD Million, 2019 - 2032)

Dravet Syndrome, End-Use Outlook (Revenue - USD Million, 2019 - 2032)

Dravet Syndrome, Distribution Channel Outlook (Revenue - USD Million, 2019 - 2032)

Dravet Syndrome, Regional Outlook (Revenue - USD Million, 2019 - 2032)

Table of Contents

1. Introduction

2. Executive Summary

3. Research Methodology

4. Global Dravet Syndrome Market Insights

5. Global Dravet Syndrome Market, by Diagnosis

6. Global Dravet Syndrome Market, by Severity

7. Global Dravet Syndrome Market, by Treatment

8. Global Dravet Syndrome Market, by Distribution Channel

9. Global Dravet Syndrome Market, by Type of seizures

10. Global Dravet Syndrome Market, by End-Use

11. Global Dravet Syndrome Market, by Geography

12. Competitive Landscape

13. Company Profiles

List of Tables